Edition:
United States

Profile: Corindus Vascular Robotics Inc (CVRS.N)

CVRS.N on New York Stock Exchange

2.74USD
17 May 2019
Change (% chg)

$0.05 (+1.86%)
Prev Close
$2.69
Open
$2.63
Day's High
$2.79
Day's Low
$2.56
Volume
37,898
Avg. Vol
18,807
52-wk High
$3.10
52-wk Low
$0.70

Corindus Vascular Robotics, Inc., incorporated on May 4, 2011, is engaged in robotic-assisted vascular interventions. The Company's CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System it brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. It operates through the development, marketing and sales of robotic-assisted vascular interventions segment. The CorPath System enables the robotic-assisted control of coronary guidewires and balloon/stent devices from the safety of a radiation-protected, ergonomic interventional cockpit. The CorPath System consists of two components: a bedside unit and an interventional cockpit. At the bedside, the CorPath System's robotic drive and sterile, single-use cassette (CorPath Cassette) translate the physician's commands into movements and manipulations of the coronary stents and catheters. The CorPath Cassette provides a single-use sterile interface with standard percutaneous coronary interventions (PCI) guidewires and devices.

The Company has installed approximately 40 CorPath Systems, including approximately two CorPath Systems in hospitals outside of the United States. The Company's radiation-shielded cockpit provides a reduction in radiation exposure for the primary operator. The cockpit allows the physician to control the procedure while seated outside of the radiation field without the need for heavy protective wear. The CorPath System also provides physicians with visualization of the procedure through the eye-level placement of monitors in the cockpit. The Company has developed vascular robotic technology to provide physicians with protection from the occupational hazards of the cath lab and to provide them with robotic precision while executing vascular procedures. Its CorPath System allows physicians to measure anatomy with sub-millimeter accuracy and manipulate the interventional device in approximately one-millimeter increments and with over 30-degree rotational movements.

The Company competes with Hansen Medical, Catheter Robotics and Stereotaxis.

Company Address

Corindus Vascular Robotics Inc

309 Waverley Oaks Rd Ste 105
WALTHAM   MA   02452-8451
P: +1508.6533335
F: +1508.2326000

Company Web Links